Sandoz moves to dismiss amended antitrust claims from US state plaintiffs over generic drugs
MLex Summary: Sandoz asked a US federal judge to dismiss US state plaintiffs’ amended US antitrust claims over generic drugs. Sandoz said that the new complaint only parrots price-fixing allegations from...To view the full article, register now.
Already a subscriber? Click here to view full article